Antibacterial agents active against Gram Negative Bacilli in phase I, II, or III clinical trials
Author:
Affiliation:
1. ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore
2. Infectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Publisher
Informa UK Limited
Link
https://www.tandfonline.com/doi/pdf/10.1080/13543784.2024.2326028
Reference129 articles.
1. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
2. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
3. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance
4. Antimicrobial Resistance in ESKAPE Pathogens
5. Antibiotics in the clinical pipeline as of December 2022
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug repurposing against antibiotic resistant bacterial pathogens;European Journal of Medicinal Chemistry;2024-12
2. New antibiotics in clinical pipeline for treating infections caused by metallo-β-lactamases producing Gram-negative bacteria;Current Opinion in Infectious Diseases;2024-08-01
3. A Review of Antibacterial Candidates with New Modes of Action;ACS Infectious Diseases;2024-07-17
4. New antibiotics to combat One Health AMR;Microbiology Australia;2024-05-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3